Public Health Agency in Major US Metropolis Expands STARLIMS License to Cover Clinical...
* Reuters is not responsible for the content in this press release.
Public Health Agency in Major US Metropolis Expands STARLIMS License to Cover
Clinical Testing, H1N1 Response
HOLLYWOOD, Fla., Aug. 27, 2009 (GLOBE NEWSWIRE) -- STARLIMS Technologies Ltd.
(Nasdaq:LIMS), a leading provider of laboratory information management systems,
or LIMS, today announced an expansion to its original contract with the public
health agency of a major U.S. city. The new agreement provides an enterprise
license for all of the agency's divisions, extending STARLIMS to the city's
health providers to streamline specimen registration, tracking and reporting.
The expanded licensing agreement increases the total contract value to
approximately $1.3 million, including licenses for the Company's software, first
year maintenance and professional services.
The original agreement of May 2009 provided STARLIMS licensing for two of the
agency's four public health divisions, while the extended agreement covers all
four divisions, including accelerated deployment in the divisions of
Microbiology and of Virology and Immunology. The agency's laboratories are
responsible for testing more than 400,000 specimens annually. One of the drivers
for this expansion was STARLIMS's proven success helping public health agencies
to meet the unique challenges of H1N1 influenza.
"We are extremely gratified to see that the public health informatics expertise
we have developed over years of collaboration with federal, state and local
agencies will be fully utilized in this major metropolitan area," said Jeff
Ferguson, COO of STARLIMS. "Over the past months, we have collaborated in an
intensely focused fashion with various public health agencies to help our
partners respond rapidly and effectively to the H1N1 influenza virus. The tools
we have developed will now be available across the public health divisions of
this large metropolis, thanks to the expansion of our licensing agreement."
STARLIMS and H1N1 Testing
STARLIMS has proven success collaborating with public health partners in H1N1
response, partnering closely with agencies such as the Louisiana Office of
Public Health, the Wyoming Department of Health, the Tennessee Department of
Health and the San Diego County Public Health Department. In a related
initiative, STARLIMS is helping develop a standard influenza testing module, as
a major component of the Laboratory Response Network for Bioterrorism (LRNB) of
the United States Centers for Disease Control and Prevention (CDC). This
collaboration involves not only the CDC and STARLIMS, but also state public
health agencies in Indiana, California and Illinois.
STARLIMS Solutions for Public Health Informatics
STARLIMS public health solutions provide the infrastructure for timely sharing
of laboratory information among state and federal public health agencies --
which is crucial for effective response to emerging public health threats,
including outbreaks of infectious diseases. STARLIMS fully supports the
guidelines set forth by the CDC and the United States Association of Public
Health Laboratories (APHL).
STARLIMS's enterprise-level information system brings together all public health
laboratory activities into a single platform, offering comprehensive reporting,
surveillance and networking capabilities. Advanced web-based capabilities are
enhanced by specialized tools and wizards, resulting in flexible solutions that
enable public health labs to manage large amounts of data while also meeting
stringent accreditation requirements.
About STARLIMS
STARLIMS Technologies Ltd. (Nasdaq:LIMS) is a leading provider of laboratory
information management systems (LIMS), with over 20 years of LIMS experience.
The Company's flagship product, STARLIMS(r), improves the reliability of
laboratory sampling processes, supports compliance with domestic and
international regulations and industry standards, and provides comprehensive
reporting, monitoring and analysis capabilities. STARLIMS software is used for
quality assurance and control, testing and monitoring, and research and
development in government, manufacturing and life sciences organizations. With
operations in the United States, Canada, the United Kingdom, Israel and Hong
Kong, the company serves over 500 organizations in 40 countries. For more
information, please see http://www.starlims.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
involve known and unknown risks and uncertainties which could cause the actual
results, performance or achievements of the company to be materially different
from those which may be expressed or implied by such statements, including,
among others, changes in general economic and business conditions, changes in
demand for products and services, the timing and amount or cancellation of
orders, loss of market share and other risks detailed from time to time in
STARLIMS's filings from time to time with the Securities and Exchange
Commission. Such filings contain and identify these and other important factors
that could cause actual results to differ materially from those contained in our
projections or forward-looking statements. Shareholders and other readers are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date on which they are made. We undertake no obligation to
update publicly or revise any forward-looking statement.
-0-
CONTACT: STARLIMS Technologies Ltd.
Tamar Harris, Director of Corporate Communications
(604) 961-6121
tamar.harris@starlims.com
Integrated Corporate Relations (ICR)
Investor Relations:
Staci Mortenson
(203) 682-8273
staci.mortenson@icrinc.com
Kori Doherty
(617) 956-6730
kori.doherty@icrinc.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters